New PET scan may solve brain tumor puzzle: regrowth or side effect?

NCT ID NCT07238322

Completed Diagnosis Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a special type of PET scan (using a tracer called FET) can accurately tell the difference between a returning brain tumor (glioma) and harmless changes caused by previous treatment. Researchers analyzed scans from 253 patients of all ages who had already been treated for glioma and showed suspicious signs on MRI. The goal was to see if FET-PET could help doctors make better decisions without needing a biopsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN NEOPLASMS GLIOMA RETROSPECTIVE STUDY

Contacts and locations

Show contact details

Locations

The University Medical Center Utrecht

Utrecht, Netherlands
University Hospital Essen

Essen, Germany
University of California, San Francisco

San Francisco, California, 94107, United States
Universityhospital Tuebingen

Tübingen, Germany